January 19, 2012
Vitae Pharmaceuticals secures $15M in debt financing to support the progress of their discovery pipeline.
Vitae Pharmaceuticals is a world leader in structure-based drug discovery (SBDD), combining our proprietary discovery engine with an integrated team of expert chemists, biologists and clinicians, to solve today's toughest and most promising drug discovery challenges.
Vitae Pharmaceuticals' SBDD approach is delivering strong performance results not only in terms of program success, but also on key criteria important to discovery organizations throughout the industry: innovation, speed and capital efficiency.
Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market opportunities, including chronic kidney disease, diabetes, atherosclerosis and Alzheimer's disease.
